Dr Tobechukwu Christian Ezike

Lecturer I, University of Nigeria
Inmaculada Yruela

Research scientist, CSIC

Dr. Inmaculada Yruela graduated and earned her doctorate in Chemistry at the University of Sevilla (Spain). She has been a visiting guest scientist at the Max Planck Institute for Chemical Energy Conversion in Mülheim an der Ruhr (Germany) and at Department of Biochemistry and Molecular Biology in Indiana University School of Medicine (USA). She is research scientist at the CSIC and group leader at Computational and Structural Biology in Estación Experimental de Aula (CSIC), Zaragoza (Spain). From the early 1990s she has been studying the relationship between the structure and function of proteins, and more recently the role of intrinsic ductiliity and plasticity of proteins in organismal complexity, multicellularity and evolution. She has led science outreach projects. She is currently member of SEBBM.
Ferhan Sagin

Chair, FEBS Education Committee, Ege University, Faculty of Medicine

Atherosclerosis, inflammatory diseases, biomarkers
Irene Diaz-Moreno

Chair of the FEBS Working Group on the Careers of Young Scientists, University of Seville - CSIC

Dr. Irene Díaz-Moreno is Full Professor of Biochemistry and Molecular Biology at the Institute of Chemical Research of the Scientific Research Centre Isla de la Cartuja – cicCartuja, in Seville (Spain). She was awarded with her Ph.D. with European mention from the University of Seville in 2005. Dr. Irene Díaz-Moreno has worked in collaboration with groups at the Universities of Göteborg (Sweden) and Leiden (The Netherlands) on molecular recognition between metalloproteins involved in electron-transfer processes. She was an EMBO postdoctoral fellow (2006–2008) at the NIMR-MRC in London (UK), working on the regulatory mechanisms of mRNA decay by RNA-binding proteins. In 2010, she got a permanent position at the University of Seville, where she is developing research projects on Biointeractomics field, as well as on the post-translational regulation of biological macromolecules.
EU-OPENSCREEN is a not-for-profit European Research Infrastructure Consortium (ERIC) for chemical biology and early drug discovery. We support all stages of a chemical tool development project, including assay adaptation, high-throughput screening, and chemical optimisation of the ‘hit’ compounds. EU-OPENSCREEN operates an open-access database and a unique, common compound collection. Our main library, the European Chemical Biology Library (ECBL), consists of over 100.000 compounds.
Fabio Fernandes

Assistant Professor, Instituto Superior Técnico

Anna Jagusiak

Researcher, Jagiellonian University Medical College

Francesco Malatesta

Professor of Chemistry and Biochemistry, [email protected]

Angel Herráez

Associate professor, University of Alcalá

biochemistry, molecular biology, bioinformatics, molecular visualisation, technology for teaching and learning
Andrea Bellelli

Prof., Sapienza University of Rome

Fiona Veira-McTiernan

Communications and Digital Platforms Associate, FEBS

I am the Communications and Digital Platforms Associate at FEBS, and I help manage content and use of online platforms and sites such as the FEBS Network, FEBS website and FEBS Congress website, but particularly on the FEBS Network. Previously I have managed the funding programmes of a number of UK research charities, mainly in the field of cancer. I have supported the income generation teams at those organisations with science communication, as well as developed e-learning resources for staff and students at the Institute of Cancer Research. I have a BSc in Biochemistry, an MSc in Nutrition and a Postgraduate Diploma in Dietetics. After years in London I have now moved back to Spain, where I continue to work as a science communicator.
The International Union of Biochemistry and Molecular Biology unites scientists in 75 countries or regions through a society, national council, or academy of sciences.

Organising committee, FEBS-IUBMB-ENABLE

Initially funded by the European Commission’s Horizon 2020 programme, the first four ENABLE conferences were held in the cities hosting the headquarters of the four entities leading the project: the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona, Spain; the Radboud Institute for Molecular Life Sciences (RIMLS) in Nijmegen, The Netherlands; The Novo Nordisk Foundation Center for Protein Research (CPR) in Copenhagen, Denmark; and the Scuola Europea di Medicina Molecolare (SEMM), in Milan, Italy. In this new cycle of conferences, FEBS, IUBMB and the four core ENABLE institutions have joined forces to share ENABLE best practices with other international research institutions. To this end, in addition to the four core research centres, other institutions can apply to become associated centres and host one of the events. For the 2024 event, FEBS-IUBMB-ENABLE will actively search for an associated centre in a non-European country to ensure that one of the events is held on another continent.